1. Business of Biotechnology The Next Wave of Innovation
by Simon 
Price: USD 25.45
Dealer: Abebooks, TextbookRush
Description: ISBN10: 1119216176, ISBN13: 9781119216179, [publisher: John Wiley & Sons, Incorporated] All orders ship SAME or NEXT business day. Expedited shipments will be received in 1-5 business days within the United States. We proudly ship to APO/FPO addresses. 100% Satisfaction Guaranteed! [Grandview Heights, OH, U.S.A.]  

2. Business of Biotechnology The Next Wave of Innovation
by Simon 
Price: USD 41.07
Dealer: Abebooks, TextbookRush
Description: ISBN10: 1119216176, ISBN13: 9781119216179, [publisher: John Wiley & Sons, Incorporated] Ships SAME or NEXT business day. We Ship to APO/FPO addr. Choose EXPEDITED shipping and receive in 2-5 business days within the United States. See our member profile for customer support contact info. We have an easy return policy. [Grandview Heights, OH, U.S.A.]  

3. Business of Biotechnology the Next Wave of Innovation
by Simon 
Price: USD 25.45
Dealer: Alibris, TextbookRush via Alibris
Description: John Wiley & Sons Inc 2017 Paperback Fair All orders ship SAME or NEXT business day. Expedited shipments will be received in 1-5 business days within the United States. We proudly ship to APO/FPO addresses. 100% Satisfaction Guaranteed! 

4. Business of Biotechnology the Next Wave of Innovation
by Simon 
Price: USD 41.07
Dealer: Alibris, TextbookRush via Alibris
Description: John Wiley & Sons Inc 2017 Paperback New All orders ship SAME or NEXT business day. Expedited shipments will be received in 1-5 business days within the United States. We proudly ship to APO/FPO addresses. 100% Satisfaction Guaranteed! 

5. Managing Biotechnology (Paperback)
by Francoise Simon 
Price: USD 49.88
Dealer: Abebooks, Grand Eagle Retail
Description: ISBN10: 1119216176, ISBN13: 9781119216179, [publisher: John Wiley & Sons Inc, New York] Softcover Paperback. A comprehensive overview of the new business context for biopharma companies, featuring numerous case studies and state-of-the-art marketing models Biotechnology has developed into a key innovation driver especially in the field of human healthcare. But as the biopharma industry continues to grow and expand its reach, development costs are colliding with aging demographics and cost-containment policies of private and public payers. Concurrently, the development and increased affordability of sophisticated digital technologies has fundamentally altered many industries including healthcare. The arrival of new information technology (infotech) companies on the healthcare scene presents both opportunities and challenges for the biopharma business model. To capitalize on new digital technologies from R&D through commercialization requires industry leaders to adopt new business models, develop new digital and data capabilities, and partner with innovators and payers worldwide. Written by two experts, both of whom have had decades of experience in the field, this book provides a comprehensive overview of the new business context and marketing models for biotech companies. Informed by extensive input by senior biotech executives and leading consultancies serving the industry, it analyzes the strategies and key success factors for the financing, development, and commercialization of novel therapeutic products, including strategies for engagement with patients, physicians and healthcare payers. Throughout case studies provide researchers, corporate marketers, senior managers, consultants, financial analysts, and other professionals involved in the biotech sector with insights, ideas, and models. JACQUALYN FOUSE, PhD, RETIRED PRESIDENT AND CHIEF OPERATING OFFICER, CELGENE Biotech companies have long been innovators, using the latest technologies to enable cutting edge science to help patients with serious diseases. This book is essential to help biotech firms understand how they canand mustapply the newest technologies including disruptive ones, alongside science, to innovate and bring new value to the healthcare system. BRUCE DARROW, MD, PhD, CHIEF MEDICAL INFORMATION OFFICER, MOUNT SINAI HEALTH SYSTEM Simon and Giovannetti have written an essential users manual explaining the complicated interplay of the patients who deserve cutting-edge medical care, the biotechnology companies (big and small) creating the breakthroughs, and the healthcare organizations and clinicians who bridge those worlds. EMMANUEL BLIN, FORMER CHIEF STRATEGY OFFICER AND SENIOR VICE PRESIDENT, BRISTOL-MYERS SQUIBB If you want to know where biopharma is going, read this book! Our industry is facing unprecedented opportunities driven by major scientific breakthroughs, while transforming itself to address accelerated landscape changes driven by digital revolutions and the emergence of value-based healthcare worldwide. In this ever-changing context, we all need to focus everything we do on the patients. They are why we exist as an industry, and this is ultimately what this insightful essay is really about. JOHN MARAGANORE, PRESIDENT AND CHIEF EXECUTIVE OFFICER, ALNYLAM PHARMACEUTICALS Since the mapping of the human genome was completed nearly 15 years ago, the biotechnology industry has led the rapid translation of raw science to todays innovative medicines. However, the work does not stop in the lab. Delivering these novel medicines to patients is a complex and multifaceted process, which is elegantly described in this new book. A comprehensive overview of the new business context for biopharma companies, featuring numerous case studies and state-of-the-art marketing models Biotechnology has developed into a key innova Shipping may be from multiple locations in the US or from the UK, depending on stock availability. [Wilmington, DE, U.S.A.] [Publication Year: 2017]  

6. Managing Biotechnology (Paperback)
by Francoise Simon 
Price: USD 53.71
Dealer: AbebooksAU, AussieBookSeller
Description: ISBN10: 1119216176, ISBN13: 9781119216179, [publisher: John Wiley & Sons Inc, New York] Softcover Paperback. A comprehensive overview of the new business context for biopharma companies, featuring numerous case studies and state-of-the-art marketing models Biotechnology has developed into a key innovation driver especially in the field of human healthcare. But as the biopharma industry continues to grow and expand its reach, development costs are colliding with aging demographics and cost-containment policies of private and public payers. Concurrently, the development and increased affordability of sophisticated digital technologies has fundamentally altered many industries including healthcare. The arrival of new information technology (infotech) companies on the healthcare scene presents both opportunities and challenges for the biopharma business model. To capitalize on new digital technologies from R&D through commercialization requires industry leaders to adopt new business models, develop new digital and data capabilities, and partner with innovators and payers worldwide. Written by two experts, both of whom have had decades of experience in the field, this book provides a comprehensive overview of the new business context and marketing models for biotech companies. Informed by extensive input by senior biotech executives and leading consultancies serving the industry, it analyzes the strategies and key success factors for the financing, development, and commercialization of novel therapeutic products, including strategies for engagement with patients, physicians and healthcare payers. Throughout case studies provide researchers, corporate marketers, senior managers, consultants, financial analysts, and other professionals involved in the biotech sector with insights, ideas, and models. JACQUALYN FOUSE, PhD, RETIRED PRESIDENT AND CHIEF OPERATING OFFICER, CELGENE Biotech companies have long been innovators, using the latest technologies to enable cutting edge science to help patients with serious diseases. This book is essential to help biotech firms understand how they canand mustapply the newest technologies including disruptive ones, alongside science, to innovate and bring new value to the healthcare system. BRUCE DARROW, MD, PhD, CHIEF MEDICAL INFORMATION OFFICER, MOUNT SINAI HEALTH SYSTEM Simon and Giovannetti have written an essential users manual explaining the complicated interplay of the patients who deserve cutting-edge medical care, the biotechnology companies (big and small) creating the breakthroughs, and the healthcare organizations and clinicians who bridge those worlds. EMMANUEL BLIN, FORMER CHIEF STRATEGY OFFICER AND SENIOR VICE PRESIDENT, BRISTOL-MYERS SQUIBB If you want to know where biopharma is going, read this book! Our industry is facing unprecedented opportunities driven by major scientific breakthroughs, while transforming itself to address accelerated landscape changes driven by digital revolutions and the emergence of value-based healthcare worldwide. In this ever-changing context, we all need to focus everything we do on the patients. They are why we exist as an industry, and this is ultimately what this insightful essay is really about. JOHN MARAGANORE, PRESIDENT AND CHIEF EXECUTIVE OFFICER, ALNYLAM PHARMACEUTICALS Since the mapping of the human genome was completed nearly 15 years ago, the biotechnology industry has led the rapid translation of raw science to todays innovative medicines. However, the work does not stop in the lab. Delivering these novel medicines to patients is a complex and multifaceted process, which is elegantly described in this new book. A comprehensive overview of the new business context for biopharma companies, featuring numerous case studies and state-of-the-art marketing models Biotechnology has developed into Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. [Truganina, VIC, Australia] [Publication Year: 2017]  

7. Managing Biotechnology (Paperback)
by Francoise Simon 
Price: USD 47.77
Dealer: AbebooksUK, CitiRetail
Description: ISBN10: 1119216176, ISBN13: 9781119216179, [publisher: John Wiley & Sons Inc, New York] Softcover Paperback. A comprehensive overview of the new business context for biopharma companies, featuring numerous case studies and state-of-the-art marketing models Biotechnology has developed into a key innovation driver especially in the field of human healthcare. But as the biopharma industry continues to grow and expand its reach, development costs are colliding with aging demographics and cost-containment policies of private and public payers. Concurrently, the development and increased affordability of sophisticated digital technologies has fundamentally altered many industries including healthcare. The arrival of new information technology (infotech) companies on the healthcare scene presents both opportunities and challenges for the biopharma business model. To capitalize on new digital technologies from R&D through commercialization requires industry leaders to adopt new business models, develop new digital and data capabilities, and partner with innovators and payers worldwide. Written by two experts, both of whom have had decades of experience in the field, this book provides a comprehensive overview of the new business context and marketing models for biotech companies. Informed by extensive input by senior biotech executives and leading consultancies serving the industry, it analyzes the strategies and key success factors for the financing, development, and commercialization of novel therapeutic products, including strategies for engagement with patients, physicians and healthcare payers. Throughout case studies provide researchers, corporate marketers, senior managers, consultants, financial analysts, and other professionals involved in the biotech sector with insights, ideas, and models. JACQUALYN FOUSE, PhD, RETIRED PRESIDENT AND CHIEF OPERATING OFFICER, CELGENE Biotech companies have long been innovators, using the latest technologies to enable cutting edge science to help patients with serious diseases. This book is essential to help biotech firms understand how they canand mustapply the newest technologies including disruptive ones, alongside science, to innovate and bring new value to the healthcare system. BRUCE DARROW, MD, PhD, CHIEF MEDICAL INFORMATION OFFICER, MOUNT SINAI HEALTH SYSTEM Simon and Giovannetti have written an essential users manual explaining the complicated interplay of the patients who deserve cutting-edge medical care, the biotechnology companies (big and small) creating the breakthroughs, and the healthcare organizations and clinicians who bridge those worlds. EMMANUEL BLIN, FORMER CHIEF STRATEGY OFFICER AND SENIOR VICE PRESIDENT, BRISTOL-MYERS SQUIBB If you want to know where biopharma is going, read this book! Our industry is facing unprecedented opportunities driven by major scientific breakthroughs, while transforming itself to address accelerated landscape changes driven by digital revolutions and the emergence of value-based healthcare worldwide. In this ever-changing context, we all need to focus everything we do on the patients. They are why we exist as an industry, and this is ultimately what this insightful essay is really about. JOHN MARAGANORE, PRESIDENT AND CHIEF EXECUTIVE OFFICER, ALNYLAM PHARMACEUTICALS Since the mapping of the human genome was completed nearly 15 years ago, the biotechnology industry has led the rapid translation of raw science to todays innovative medicines. However, the work does not stop in the lab. Delivering these novel medicines to patients is a complex and multifaceted process, which is elegantly described in this new book. A comprehensive overview of the new business context for biopharma companies, featuring numerous case studies and state-of-the-art marketing models Biotechnology has developed into Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. [Stevenage, United Kingdom] [Publication Year: 2017]  

8. Managing Biotechnology - From Science to Market in the Digital Age
by Simon, F 
Price: USD 46.34
Dealer: Alibris
Description: Hoboken Wiley-Blackwell 2017 Paperback New. 320 p. Intended for professional and scholarly audience. 

9. Managing Biotechnology : From Science to Market in the Digital Age
by Simon, Francoise, Ph.D.; Giovannetti, Glen 
Price: USD 50.99
Dealer: Abebooks, GreatBookPrices
Description: ISBN10: 1119216176, ISBN13: 9781119216179, [publisher: Wiley] Softcover [Columbia, MD, U.S.A.] [Publication Year: 2017]  

10. Managing Biotechnology : From Science to Market in the Digital Age
by Simon, Francoise, Ph.D.; Giovannetti, Glen 
Price: USD 47.76
Dealer: AbebooksUK, GreatBookPricesUK
Description: ISBN10: 1119216176, ISBN13: 9781119216179, [publisher: Wiley] Softcover [Castle Donington, DERBY, United Kingdom] [Publication Year: 2017]  

11. Managing Biotechnology a From Science to Market in the Digital Age
by Simon Francoise/ Giovannetti Glen 
Price: USD 59.56
Dealer: Biblio, Revaluation Books
Description: John Wiley & Sons Inc, Date: 2017. Paperback. New. 250 pages. 9.00x6.00x0.75 inches. 2017. John Wiley & Sons Inc ISBN 1119216176 9781119216179 [GB] 

12. Managing Biotechnology From Science to Market in the Digital Age
by F Simon 
Price: USD 51.61
Dealer: AbebooksUK, PBShop.store UK
Description: ISBN10: 1119216176, ISBN13: 9781119216179, [publisher: Wiley-Blackwell] Softcover New Book. Shipped from UK. Established seller since 2000. [Fairford, GLOS, United Kingdom] [Publication Year: 2017]  

13. Managing Biotechnology From Science to Market in the Digital Age
by F Simon 
Price: USD 57.95
Dealer: Alibris, Books2anywhere via Alibris
Description: Wiley-Blackwell 12/8/2017 12: 00: 00 AM Softcover PLEASE NOTE, WE DO NOT SHIP TO DENMARK. New Book. Shipped from UK in 4 to 14 days. Established seller since 2000. Please note we cannot offer an expedited shipping service from the UK. 

14. Managing Biotechnology From Science to Market in the Digital Age
by F Simon 
Price: USD 60.94
Dealer: Alibris, Paperbackshop International via Alibris
Description: Wiley-Blackwell 12/8/2017 12: 00: 00 AM Softcover PLEASE NOTE, WE DO NOT SHIP TO DENMARK. New Book. Shipped from UK in 4 to 14 days. Established seller since 2000. Please note we cannot offer an expedited shipping service from the UK. 

15. Managing Biotechnology – From Science to Market in the Digital Age
by Simon, Francoise/ Giovannetti, Glen 
Price: USD 60.42
Dealer: AbebooksUK, Revaluation Books
Description: ISBN10: 1119216176, ISBN13: 9781119216179, [publisher: John Wiley & Sons Inc] Softcover 250 pages. 9.00x6.00x0.75 inches. In Stock. [Exeter, United Kingdom] [Publication Year: 2017]  

16. Managing Biotechnology – From Science to Market in the Digital Age
by Simon, Francoise/ Giovannetti, Glen 
Price: USD 71.37
Dealer: Alibris, Revaluation Books via Alibris
Description: John Wiley & Sons Inc 2017 Softcover New 250 pages. 9.00x6.00x0.75 inches. 

17. Managing Biotechnology: From Science to Market in the Digital Age (Paperback Or Softback)
by Simon, Francoise 
Price: USD 57.27
Dealer: Alibris, BargainBookStores via Alibris
Description: Wiley 10/16/2017 Paperback or Softback New in New jacket Managing Biotechnology: From Science to Market in the Digital Age (Paperback or Softback) 

18. Managing Biotechnology: From Science to Market in the Digital Age (Paperback or Softback)
by Simon, Francoise 
Price: USD 55.19
Dealer: Abebooks, BargainBookStores
Description: ISBN10: 1119216176, ISBN13: 9781119216179, [publisher: Wiley 10/16/2017] Softcover Managing Biotechnology: From Science to Market in the Digital Age 0.93 [Grand Rapids, MI, U.S.A.] [Publication Year: 2017]  

19. Managing Biotechnology: From Science to Market in the Digital Age
by Francoise Simon 
Price: USD 54.39
Dealer: Biblio, The Saint Bookstore
Description: Paperback / softback. New. ISBN 1119216176 9781119216179 [GB] 

20. Managing Biotechnology: From Science to Market in the Digital Age
by Simon Francoise 
Price: USD 54.71
Dealer: Biblio, Bonita
Description: paperback. Good. Access codes and supplements are not guaranteed with used items. May be an ex-library book. ISBN 1119216176 9781119216179 [US] 

21. Managing Biotechnology: From Science to Market in the Digital Age
by Simon Francoise 
Price: USD 41.52
Dealer: Biblio, Ergodebooks
Description: Wiley, Date: 2017-10-16. 1. paperback. Used:Good. Wiley ISBN 1119216176 9781119216179 [US] 

22. Managing Biotechnology: From Science to Market in the Digital Age
by Simon Francoise 
Price: USD 22.84
Dealer: Biblio, Ergodebooks
Description: Wiley, Date: 2017-10-16. 1. paperback. Used: Good. Wiley ISBN 1119216176 9781119216179 [US] 

23. Managing Biotechnology: From Science to Market in the Digital Age
by Simon Francoise; Giovannetti Glen 
Price: USD 42.00
Dealer: Biblio, B Street Books, ABAA
Description: Wiley, Date: 2017. Soft cover. As New. Book is as new and all pages are clean and unmarked. 2017. Wiley ISBN 1119216176 9781119216179 [US] 

24. Managing Biotechnology: From Science to Market in the Digital Age
by Simon Francoise; Giovannetti Glen 
Price: USD 64.13
Dealer: Biblio, SGS Trading Inc
Description: Wiley, Date: 2017-10-16. Paperback. Good. Textbook, May Have Highlights, Notes and/or Underlining, BOOK ONLYNO ACCESS CODE, NO CD, Ships with Emailed Tracking Wiley ISBN 1119216176 9781119216179 [US] 

25. Managing Biotechnology: From Science to Market in the Digital Age
by Simon Francoise\Giovannetti Glen 
Price: USD 32.37
Dealer: Biblio, Baby Starren
Description: Wiley, 9/1/Date: 2017. New. Wiley, 9/1/2017 New All orders ship SAME or NEXT business day Expedited shipments will be received in 5-12 business days within the United States 100% Satisfaction Guaranteed! 2017. Wiley ISBN 1119216176 9781119216179 [VN] 

26. Managing Biotechnology: From Science to Market in the Digital Age
by Francoise Simon, Glen Giovannetti 
Price: USD 55.17
Dealer: AbebooksUK, Chiron Media
Description: ISBN10: 1119216176, ISBN13: 9781119216179, [publisher: Wiley-Blackwell 2017-11-06] Softcover [Wallingford, United Kingdom] [Publication Year: 2017]  

27. Managing Biotechnology: From Science to Market in the Digital Age
by Francoise Simon 
Price: USD 70.10
Dealer: Abebooks, Kennys Bookshop and Art Galleries Ltd.
Description: ISBN10: 1119216176, ISBN13: 9781119216179, [publisher: John Wiley & Sons Inc] Softcover First Edition Num Pages: 250 pages. BIC Classification: KC. Weight in Grams: 666. . 2017. 1st Edition. Paperback. . . . . [Galway, GY, Ireland] [Publication Year: 2017]  

28. Managing Biotechnology: From Science to Market in the Digital Age
by Francoise Simon 
Price: USD 80.90
Dealer: Abebooks, Kennys Bookstore
Description: ISBN10: 1119216176, ISBN13: 9781119216179, [publisher: John Wiley & Sons Inc] Softcover Num Pages: 250 pages. BIC Classification: KC. Weight in Grams: 666. . 2017. 1st Edition. Paperback. . . . . Books ship from the US and Ireland. [Olney, MD, U.S.A.] [Publication Year: 2017]  

29. Managing Biotechnology: From Science to Market in the Digital Age
by Simon, Francoise, and Giovannetti, Glen 
Price: USD 66.66
Dealer: Alibris, Booksplease via Alibris
Description: New York John Wiley & Sons Inc 2017 Paperback New. Intended for professional and scholarly audience. 

30. Managing Biotechnology: From Science to Market in the Digital Age
by Simon, Francoise 
Price: USD 99.13
Dealer: Alibris, Bonita via Alibris
Description: John Wiley & Sons Inc 2017 paperback New 

31. Managing Biotechnology: From Science to Market in the Digital Age
by Simon, Francoise 
Price: USD 47.09
Dealer: Alibris, Bonita via Alibris
Description: Wiley 2017 paperback Good Access codes and supplements are not guaranteed with used items. May be an ex-library book. 

32. Managing Biotechnology: From Science to Market in the Digital Age
by Simon, Francoise; Giovannetti, Glen 
Price: USD 49.34
Dealer: Alibris, Book Words via Alibris
Description: Wiley 2017-10-16 Paperback Good USED-VARIOUS AMOUNTS OF WEAR-POSSIBLE HIGHLIGHTS-WE CANNOT GUARANTEE SUPPLEMENTS SUCH AS CD, ACCESS CODE, OR INFO TRAC. 

33. Managing Biotechnology: From Science to Market in the Digital Age
by Simon, Francoise; Giovannetti, Glen 
Price: USD 51.11
Dealer: Alibris, TEXTSHUB via Alibris
Description: Wiley 2017-10-16 Paperback Good Textbook, May Have Highlights, Notes and/or Underlining, BOOK ONLYNO ACCESS CODE, NO CD, Ships with Emailed Tracking. 

34. Managing Biotechnology: From Science to Market in the Digital Age
by Simon, F 
Price: USD 57.89
Dealer: Abebooks, Brook Bookstore
Description: ISBN10: 1119216176, ISBN13: 9781119216179, [publisher: Wiley–Blackwell] Softcover [Milano, MI, Italy] [Publication Year: 2017]  

35. Managing Biotechnology: From Science to Market in the Digital Age
by Simon, Francoise, Giovannetti, Glen 
Price: USD 46.57
Dealer: AbebooksDE, medimops
Description: ISBN10: 1119216176, ISBN13: 9781119216179, [publisher: Wiley] Softcover Gut/Very good: Buch bzw. Schutzumschlag mit wenigen Gebrauchsspuren an Einband, Schutzumschlag oder Seiten. / Describes a book or dust jacket that does show some signs of wear on either the binding, dust jacket or pages. [Berlin, Germany] [Publication Year: 2017]  

36. Managing Biotechnology: From Science to Market in the Digital Age
by Simon, Francoise, Giovannetti, Glen 
Price: USD 41.81
Dealer: ZVAB, medimops
Description: ISBN10: 1119216176, ISBN13: 9781119216179, [publisher: Wiley] Softcover Gut/Very good: Buch bzw. Schutzumschlag mit wenigen Gebrauchsspuren an Einband, Schutzumschlag oder Seiten. / Describes a book or dust jacket that does show some signs of wear on either the binding, dust jacket or pages. [Berlin, Germany] [Publication Year: 2017]  

37. Managing Biotechnology: From Science to Market in the Digital Age
by Simon, Francoise 
Price: USD 33.82
Dealer: Abebooks, Books of the Smoky Mountains
Description: ISBN10: 1119216176, ISBN13: 9781119216179, [publisher: Wiley] Softcover Gently used book with ongoing seller support until you're fully satisfied with your purchase. [Del Rio, TN, U.S.A.] [Publication Year: 2017]  

38. Managing Biotechnology: From Science to Market in the Digital Age
by Simon, Francoise 
Price: USD 33.78
Dealer: Abebooks, Byrd Books
Description: ISBN10: 1119216176, ISBN13: 9781119216179, [publisher: Wiley] Softcover In Used Condition [Austin, TX, U.S.A.] [Publication Year: 2017]  

39. Managing Biotechnology: From Science to Market in the Digital Age
by Simon, Francoise 
Price: USD 34.49
Dealer: Abebooks, Front Cover Books
Description: ISBN10: 1119216176, ISBN13: 9781119216179, [publisher: Wiley] Softcover [Denver, CO, U.S.A.] [Publication Year: 2017]  

40. Managing Biotechnology: From Science to Market in the Digital Age
by Simon, Francoise 
Price: USD 35.51
Dealer: Abebooks, GoldBooks
Description: ISBN10: 1119216176, ISBN13: 9781119216179, [publisher: Wiley] Softcover New Copy. Customer Service Guaranteed [Denver, CO, U.S.A.] [Publication Year: 2017]  

41. Managing Biotechnology: From Science to Market in the Digital Age
by Simon, Francoise 
Price: USD 29.17
Dealer: Abebooks, GoldBooks
Description: ISBN10: 1119216176, ISBN13: 9781119216179, [publisher: Wiley] Softcover Very Good Copy. Customer Service Guaranteed [Denver, CO, U.S.A.] [Publication Year: 2017]  

42. Managing Biotechnology: From Science to Market in the Digital Age
by Simon, Francoise 
Price: USD 35.80
Dealer: Abebooks, GoldenDragon
Description: ISBN10: 1119216176, ISBN13: 9781119216179, [publisher: Wiley] Softcover Buy for Great customer experience [Houston, TX, U.S.A.] [Publication Year: 2017]  

43. Managing Biotechnology: From Science to Market in the Digital Age
by Simon, Francoise 
Price: USD 37.76
Dealer: Abebooks, Grumpys Fine Books
Description: ISBN10: 1119216176, ISBN13: 9781119216179, [publisher: Wiley] Softcover Prompt service guaranteed. [Tijeras, NM, U.S.A.] [Publication Year: 2017]  

44. Managing Biotechnology: From Science to Market in the Digital Age
by Simon, Francoise 
Price: USD 38.26
Dealer: Abebooks, Wizard Books
Description: ISBN10: 1119216176, ISBN13: 9781119216179, [publisher: Wiley] Softcover Used [Long Beach, CA, U.S.A.] [Publication Year: 2017]  

45. Managing Biotechnology: From Science to Market in the Digital Age
by Simon, Francoise 
Price: USD 35.29
Dealer: Abebooks, Wizard Books
Description: ISBN10: 1119216176, ISBN13: 9781119216179, [publisher: Wiley] Softcover New [Long Beach, CA, U.S.A.] [Publication Year: 2017]  

46. Managing Biotechnology: From Science to Market in the Digital Age
by Simon, Francoise; Giovannetti, Glen 
Price: USD 38.95
Dealer: Abebooks, B Street Books, ABAA and ILAB
Description: ISBN10: 1119216176, ISBN13: 9781119216179, [publisher: Wiley] Softcover Book is as new and all pages are clean and unmarked. [San Mateo, CA, U.S.A.] [Publication Year: 2017]  

47. Managing Biotechnology: From Science to Market in the Digital Age
by Simon, Francoise; Giovannetti, Glen 
Price: USD 32.06
Dealer: Abebooks, Book Deals
Description: ISBN10: 1119216176, ISBN13: 9781119216179, [publisher: Wiley] Softcover Acceptable/Fair condition. Book is worn, but the pages are complete, and the text is legible. Has wear to binding and pages, may be ex-library. 1.12 [Tucson, AZ, U.S.A.] [Publication Year: 2017]  

48. Managing Biotechnology: From Science to Market in the Digital Age
by Simon, Francoise; Giovannetti, Glen 
Price: USD 29.41
Dealer: Abebooks, Book Deals
Description: ISBN10: 1119216176, ISBN13: 9781119216179, [publisher: Wiley] Softcover Very Good condition. Shows only minor signs of wear, and very minimal markings inside (if any). 1.12 [Tucson, AZ, U.S.A.] [Publication Year: 2017]  

49. Managing Biotechnology: From Science to Market in the Digital Age
by Simon, Francoise; Giovannetti, Glen 
Price: USD 53.95
Dealer: Abebooks, Books Unplugged
Description: ISBN10: 1119216176, ISBN13: 9781119216179, [publisher: Wiley] Softcover Buy with confidence! Book is in new, never-used condition [Amherst, NY, U.S.A.] [Publication Year: 2017]  

50. Managing Biotechnology: From Science to Market in the Digital Age
by Simon, Francoise; Giovannetti, Glen 
Price: USD 29.41
Dealer: Abebooks, Books Unplugged
Description: ISBN10: 1119216176, ISBN13: 9781119216179, [publisher: Wiley] Softcover Buy with confidence! Book is in acceptable condition with wear to the pages, binding, and some marks within 1.12 [Amherst, NY, U.S.A.] [Publication Year: 2017]